Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome

References

1. ↵
   Raroque HG, Orrison WW, Rosenberg GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neuroradiology 1990;40:167–69

   CrossRef
2. Truwit CL, Denaro CP, Lake JR, et al. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–59

   Abstract/FREE Full Text
3. ↵
   Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872–80

   CrossRefPubMed
4. Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082–85

   Abstract/FREE Full Text
5. ↵
   Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–14

   Abstract/FREE Full Text
6. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500

   CrossRefPubMedWeb of Science
7. Provenzale JM, Petrella JR, Cruz LC, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001;22:1455–61

   Abstract/FREE Full Text
8. Covarrubias DJ, Leutmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038–48

   Abstract/FREE Full Text
9. ↵
   Rippe DJ, Edwards MK, Schrodt JF, et al. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. J Comput Assist Tomogr 1988;12:1078–81

   PubMed
10. Vaughn DJ, Jarvik JG, Hackney D, et al. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993;14:1014–16

    Abstract/FREE Full Text
11. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415–17

    Abstract
12. ↵
    Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the incidence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–69

    Abstract/FREE Full Text
13. ↵
    Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179–90

    Abstract/FREE Full Text
14. ↵
    Lin JT, Wang SJ, Fuh JL, et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003;24:102–04

    Abstract/FREE Full Text
15. Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344–46

    Abstract
16. Sengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–90

    Abstract
17. Bartynski WS, Sanghvi A. Neuroimaging of delayed eclampsia. Report of 3 cases and review of the literature. J Comput Assist Tomogr 2003;27:699–713

    CrossRefPubMedWeb of Science
18. Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165–72

    PubMedWeb of Science
19. ↵
    Engelter ST, Petrella JR, Alberts MJ, et al. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol 1999;173:1491–93

    PubMed
20. ↵
    Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825–30

    Abstract/FREE Full Text
21. ↵
    Ferris EJ. Arteritis. In: Newton TH, Potts DG. Radiology of the skull and brain: Angiography. Reprinted by Great Neck, New York: MediBooks, 1986; original printing by Mosby1974 :2566–97
22. ↵
    Osborne A. Nonatheromatous vasculopathy. In: Osborne A. Diagnostic cerebral angiography, 2nd ed. Philadelphia: Lippincott Williams and Wilkins;1999 :341–58
23. ↵
    Agresti A, Mehta CR, Patel NR. Exact inference for contingency tables with ordered categories. J Am Stat Assoc 1990;85:453–58

    CrossRefWeb of Science
24. ↵
    Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339–46

    CrossRefPubMedWeb of Science
25. ↵
    Cerebral blood flow, cerebrospinal fluid, and brain metabolism. In: Guyton AC, Hall, JE. Textbook of medical physiology. Philadelphia: Elsevier;2006 :761–68
26. ↵
    Zwienenberg-Lee M, Muizelaar JP. Clinical pathophysiology of traumatic brain injury. In: Winn HR, ed. Youmans neurological surgery, 5th ed. Philadelphia: Saunders;2004 :5039–63
27. ↵
    Busija DW, Heistad DD, Marcus ML. Effects of sympathetic nerves on cerebral vessels during acute, moderate increases in arterial pressure in dogs and cats. Circ Res 1980;46:696–702

    FREE Full Text
28. ↵
    Kontos HA, Wei EP, Navari RM, et al. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:H371–83

    PubMedWeb of Science
29. ↵
    MacKenzie ET, Strandgaard S, Graham DI, et al. Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood brain barrier. Circ Res 1976;39:33–41

    Abstract/FREE Full Text
30. ↵
    Cunningham FG, Gant NF, Leveno KJ, et al. Hypertensive disorders in pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, et al, eds. Williams Obstetrics, 21st ed.2001 :567–618
31. ↵
    Munford RS. Sepsis, severe sepsis, and septic shock. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. Philadelphia: Elsevier;2005 :906–26
32. Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000;9:299–306

    CrossRefPubMed
33. Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003;17:1150–56

    CrossRefPubMed
34. Bartynski WS, Zeigler ZR, Shadduck RK, et al. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoietic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care 2005;3:33–45

    CrossRefPubMed
35. ↵
    Daly AS, Xenocostas A, Lipton JH. Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002;30:709–15

    CrossRefPubMedWeb of Science
36. ↵
    Parent C, Eichacker PQ. Neutrophil and endothelial cell interactions in sepsis. The role of adhesion molecules. Infect Dis Clin North Am 1999;13:427–47, x

    CrossRefPubMedWeb of Science
37. ↵
    McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 1996 :752–63
38. ↵
    Wanecek M, Weitzberg E, Rudehill A, et al. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 2000;407:1–15

    CrossRefPubMedWeb of Science
39. ↵
    Mantovani A, Bussolino F, Dejanna E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591–99

    Abstract
40. ↵
    Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002;125:2549–57

    Abstract/FREE Full Text